Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Arthritis Rheum. 2010 Aug;62(8):2510–2516. doi: 10.1002/art.27485

Figure 3. FSTL-1 is elevated in sera of patients with active systemic-onset JRA.

Figure 3

Sera from children with JRA, as well as pediatric control sera, were assayed for FSTL-1. Each circle represents an individual sample. Black circles indicate subjects with laboratory evidence of active disease (ESR ≥ 20 mm/hr or a platelet count ≥ 380×109/L). White circles indicate subjects with normal ESR and platelet count. Grey circles indicate subjects who did not have an ESR or platelet count. The horizontal line is drawn at a level of 18 ng/ml.

HHS Vulnerability Disclosure